Usability of FDA-approved medication guides
- PMID: 22566170
- PMCID: PMC3509312
- DOI: 10.1007/s11606-012-2068-7
Usability of FDA-approved medication guides
Abstract
Background: Medication guides are required documents to be distributed to patients in order to convey serious risks associated with certain prescribed medicines. Little is known about the effectiveness of this information to adequately inform patients on safe use.
Objective: To examine the readability, suitability, and comprehensibility of medication guides, particularly for those with limited literacy.
Design: Assessments of suitability and readability of 185 medication guides, and a sub-study examining change in suitability and readability from 2006 to 2010 among 32 of the medication guides (Study 1); 'open book' comprehension assessment of medication guides (Study 2).
Setting: Two general internal medicine clinics in Chicago, IL.
Patients: Four hundred and forty-nine adults seeking primary care services, ages 18-85.
Measurements: For Study 1, the Suitability Assessment of Materials (SAM) and Lexile score for readability. For Study 2, a tailored comprehension assessment of content found in three representative medication guides.
Results: The 185 analyzed medication guides were on average 1923 words (SD = 1022), with a mean reading level of 10-11th grade. Only one medication guide was deemed suitable in SAM analyses. None provided summaries or reviews, or framed the context first, while very few were rated as having made the purpose evident (8 %), or limited the scope of content (22 %). For Study 2, participants' comprehension of medication guides was poor (M = 52.7 % correct responses, SD = 22.6). In multivariable analysis, low and marginal literacy were independently associated with poorer understanding (β = -14.3, 95 % CI -18.0 - -10.6, p < 0.001; low: β = -23.7, 95 % CI -28.3 - -19.0, p < 0.001).
Conclusion: Current medication guides are of little value to patients, as they are too complex and difficult to understand especially for individuals with limited literacy. Explicit guidance is offered for improving these print materials.
Figures
Comment in
-
Getting to better prescription drug information.J Gen Intern Med. 2012 Dec;27(12):1582-4. doi: 10.1007/s11606-012-2222-2. J Gen Intern Med. 2012. PMID: 23129158 Free PMC article. No abstract available.
Similar articles
-
A critical review of FDA-approved Medication Guides.Patient Educ Couns. 2006 Sep;62(3):316-22. doi: 10.1016/j.pec.2006.06.010. Epub 2006 Aug 1. Patient Educ Couns. 2006. PMID: 16884888
-
Comparative effectiveness of patient-centered strategies to improve FDA medication guides.Med Care. 2014 Sep;52(9):781-9. doi: 10.1097/MLR.0000000000000182. Med Care. 2014. PMID: 25119953 Clinical Trial.
-
Suitability and readability assessment of educational print resources related to physical activity: implications and recommendations for practice.Patient Educ Couns. 2008 Aug;72(2):342-9. doi: 10.1016/j.pec.2008.03.010. Epub 2008 May 2. Patient Educ Couns. 2008. PMID: 18450409
-
Readability of patient education materials in ophthalmology: a single-institution study and systematic review.BMC Ophthalmol. 2016 Aug 3;16:133. doi: 10.1186/s12886-016-0315-0. BMC Ophthalmol. 2016. PMID: 27487960 Free PMC article. Review.
-
Readability of Written Materials for CKD Patients: A Systematic Review.Am J Kidney Dis. 2015 Jun;65(6):842-50. doi: 10.1053/j.ajkd.2014.11.025. Epub 2015 Feb 4. Am J Kidney Dis. 2015. PMID: 25661679 Review.
Cited by
-
Assessment of the U.S. Food and Drug Administration's risk evaluation and mitigation strategy (REMS) for prasugrel (EFFIENT): A narrative review.Am Heart J Plus. 2024 Feb;38:100359. doi: 10.1016/j.ahjo.2024.100359. Epub 2024 Jan 8. Am Heart J Plus. 2024. PMID: 38371270 Free PMC article.
-
What do patients on methotrexate need and expect at the clinic? An online patient survey.Rheumatol Int. 2023 Apr;43(4):735-741. doi: 10.1007/s00296-022-05249-3. Epub 2022 Nov 27. Rheumatol Int. 2023. PMID: 36436083
-
Effects of additional context information in prescription drug information sheets on comprehension and risk and efficacy perceptions.J Pharm Policy Pract. 2022 Mar 1;15(1):15. doi: 10.1186/s40545-021-00386-9. J Pharm Policy Pract. 2022. PMID: 35232474 Free PMC article.
-
An Innovative Health Literacy Approach Designed to Improve Patient Understanding of Medication Labeling.Ther Innov Regul Sci. 2021 Nov;55(6):1180-1192. doi: 10.1007/s43441-021-00325-5. Epub 2021 Aug 2. Ther Innov Regul Sci. 2021. PMID: 34341945 Free PMC article.
-
Communicative and Discursive Perspectives on the Medication Experience.Pharmacy (Basel). 2021 Feb 17;9(1):42. doi: 10.3390/pharmacy9010042. Pharmacy (Basel). 2021. PMID: 33671135 Free PMC article.
References
-
- Department of Health and Human Services Prescription drug product labeling: medication guide requirements; final rule. Fed Regist. 1998;63:66378–400. - PubMed
-
- Department of Health and Human Services. medication guides for Prescription Drug Products. Title 21 Code of Federal Regulations. Pt. 208. 2004:115-6.
-
- U.S. Food and Drug Administration. Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments and Proposed REMS Modifications. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformati.... Accessed March 29, 2012
-
- U.S. Food and Drug Administration, Center for Drug Evaluation Research (CDER). Guidance for Industry: medication guides - Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformati.... Accessed March 29, 2012.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
